

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | folic acid-containing compound biosynthetic process (GO:0009396) | 5.00998581 |
| 2 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.61007636 |
| 3 | regulation of translational fidelity (GO:0006450) | 4.39206277 |
| 4 | * spliceosomal tri-snRNP complex assembly (GO:0000244) | 4.28000655 |
| 5 | mitotic nuclear envelope disassembly (GO:0007077) | 4.19598168 |
| 6 | paraxial mesoderm development (GO:0048339) | 4.06281605 |
| 7 | nuclear envelope disassembly (GO:0051081) | 3.96841097 |
| 8 | membrane disassembly (GO:0030397) | 3.96841097 |
| 9 | formation of translation preinitiation complex (GO:0001731) | 3.89965570 |
| 10 | pentose-phosphate shunt (GO:0006098) | 3.88442836 |
| 11 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.88198691 |
| 12 | IMP biosynthetic process (GO:0006188) | 3.88183740 |
| 13 | nuclear pore organization (GO:0006999) | 3.87925721 |
| 14 | DNA unwinding involved in DNA replication (GO:0006268) | 3.87004778 |
| 15 | histone H2A ubiquitination (GO:0033522) | 3.80981473 |
| 16 | histone H2A monoubiquitination (GO:0035518) | 3.78389484 |
| 17 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.73127783 |
| 18 | regulation of gene silencing by miRNA (GO:0060964) | 3.73127783 |
| 19 | regulation of gene silencing by RNA (GO:0060966) | 3.73127783 |
| 20 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.72352682 |
| 21 | protein retention in ER lumen (GO:0006621) | 3.68816715 |
| 22 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.62986313 |
| 23 | nuclear pore complex assembly (GO:0051292) | 3.55517205 |
| 24 | glucose catabolic process (GO:0006007) | 3.52685090 |
| 25 | regulation of mitotic spindle organization (GO:0060236) | 3.52065329 |
| 26 | nucleobase biosynthetic process (GO:0046112) | 3.51920161 |
| 27 | protein localization to kinetochore (GO:0034501) | 3.48407039 |
| 28 | regulation of spindle organization (GO:0090224) | 3.46713494 |
| 29 | negative regulation of histone methylation (GO:0031061) | 3.43931306 |
| 30 | negative regulation of cell size (GO:0045792) | 3.42337375 |
| 31 | proline metabolic process (GO:0006560) | 3.40396106 |
| 32 | NADPH regeneration (GO:0006740) | 3.38435106 |
| 33 | IMP metabolic process (GO:0046040) | 3.35421332 |
| 34 | Golgi transport vesicle coating (GO:0048200) | 3.33912453 |
| 35 | COPI coating of Golgi vesicle (GO:0048205) | 3.33912453 |
| 36 | activation of Rac GTPase activity (GO:0032863) | 3.33447104 |
| 37 | cell-substrate adherens junction assembly (GO:0007045) | 3.30186297 |
| 38 | focal adhesion assembly (GO:0048041) | 3.30186297 |
| 39 | purine nucleobase biosynthetic process (GO:0009113) | 3.30010076 |
| 40 | regulation of histone H3-K27 methylation (GO:0061085) | 3.28980190 |
| 41 | folic acid metabolic process (GO:0046655) | 3.28293652 |
| 42 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.27005089 |
| 43 | glucose 6-phosphate metabolic process (GO:0051156) | 3.26802659 |
| 44 | heterochromatin organization (GO:0070828) | 3.26220039 |
| 45 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.23050372 |
| 46 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.21324057 |
| 47 | dosage compensation (GO:0007549) | 3.21204277 |
| 48 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.20926526 |
| 49 | adherens junction assembly (GO:0034333) | 3.20871415 |
| 50 | positive regulation of nuclease activity (GO:0032075) | 3.18992251 |
| 51 | pre-miRNA processing (GO:0031054) | 3.18941907 |
| 52 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.17450041 |
| 53 | protein maturation by protein folding (GO:0022417) | 3.15539531 |
| 54 | mitotic chromosome condensation (GO:0007076) | 3.15400589 |
| 55 | DNA duplex unwinding (GO:0032508) | 3.15216963 |
| 56 | DNA geometric change (GO:0032392) | 3.15088322 |
| 57 | nuclear envelope organization (GO:0006998) | 3.15034006 |
| 58 | negative regulation of chromosome segregation (GO:0051985) | 3.07307448 |
| 59 | tetrahydrofolate metabolic process (GO:0046653) | 3.05903700 |
| 60 | mitotic spindle assembly checkpoint (GO:0007094) | 3.04101946 |
| 61 | mitotic sister chromatid segregation (GO:0000070) | 3.03002000 |
| 62 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.01927442 |
| 63 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.99932910 |
| 64 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.99932910 |
| 65 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.99932910 |
| 66 | negative regulation of sister chromatid segregation (GO:0033046) | 2.99932910 |
| 67 | translesion synthesis (GO:0019985) | 2.99526802 |
| 68 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.99144599 |
| 69 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.99144599 |
| 70 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.99006561 |
| 71 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.98135576 |
| 72 | spindle assembly checkpoint (GO:0071173) | 2.97466076 |
| 73 | protein-DNA complex disassembly (GO:0032986) | 2.96804261 |
| 74 | nucleosome disassembly (GO:0006337) | 2.96804261 |
| 75 | protein localization to endosome (GO:0036010) | 2.95814833 |
| 76 | sister chromatid segregation (GO:0000819) | 2.95541528 |
| 77 | mRNA stabilization (GO:0048255) | 2.92322975 |
| 78 | RNA stabilization (GO:0043489) | 2.92322975 |
| 79 | glycine metabolic process (GO:0006544) | 2.91312596 |
| 80 | regulation of RNA export from nucleus (GO:0046831) | 2.90324878 |
| 81 | mitotic spindle checkpoint (GO:0071174) | 2.90293646 |
| 82 | NADH metabolic process (GO:0006734) | 2.89720653 |
| 83 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.89657026 |
| 84 | snRNA metabolic process (GO:0016073) | 2.89217622 |
| 85 | apoptotic process involved in morphogenesis (GO:0060561) | 2.87897116 |
| 86 | regulation of nuclease activity (GO:0032069) | 2.86775345 |
| 87 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.86714893 |
| 88 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.86484144 |
| 89 | postreplication repair (GO:0006301) | 2.85654466 |
| 90 | maturation of SSU-rRNA (GO:0030490) | 2.85412286 |
| 91 | pinocytosis (GO:0006907) | 2.84441596 |
| 92 | chaperone-mediated protein complex assembly (GO:0051131) | 2.83251498 |
| 93 | mitotic metaphase plate congression (GO:0007080) | 2.82127949 |
| 94 | GDP-mannose metabolic process (GO:0019673) | 2.79842282 |
| 95 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.79748526 |
| 96 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.79477843 |
| 97 | ER-nucleus signaling pathway (GO:0006984) | 2.78750085 |
| 98 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.78553882 |
| 99 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.77612076 |
| 100 | regulation of histone H3-K9 methylation (GO:0051570) | 2.76673586 |
| 101 | maternal placenta development (GO:0001893) | 2.75622423 |
| 102 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.75475949 |
| 103 | protein export from nucleus (GO:0006611) | 2.75403631 |
| 104 | negative regulation of viral release from host cell (GO:1902187) | 2.74365702 |
| 105 | histone arginine methylation (GO:0034969) | 2.73999732 |
| 106 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.73132567 |
| 107 | spindle checkpoint (GO:0031577) | 2.72930749 |
| 108 | DNA replication initiation (GO:0006270) | 2.72594003 |
| 109 | chromatin assembly (GO:0031497) | 2.71088253 |
| 110 | regulation of cholesterol homeostasis (GO:2000188) | 2.70530110 |
| 111 | regulation of translational elongation (GO:0006448) | 2.69611316 |
| 112 | modulation by virus of host process (GO:0019054) | 2.69506400 |
| 113 | mitochondrial fusion (GO:0008053) | 2.69247141 |
| 114 | glycolytic process (GO:0006096) | 2.69190559 |
| 115 | folic acid-containing compound metabolic process (GO:0006760) | 2.67344305 |
| 116 | modulation by symbiont of host cellular process (GO:0044068) | 2.66960234 |
| 117 | peptidyl-arginine methylation (GO:0018216) | 2.66622373 |
| 118 | peptidyl-arginine N-methylation (GO:0035246) | 2.66622373 |
| 119 | activation of MAPKKK activity (GO:0000185) | 2.66489865 |
| 120 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.66483507 |
| 121 | regulation of chromosome segregation (GO:0051983) | 2.65868489 |
| 122 | cellular response to unfolded protein (GO:0034620) | 2.65251184 |
| 123 | lysine metabolic process (GO:0006553) | 2.65150355 |
| 124 | lysine catabolic process (GO:0006554) | 2.65150355 |
| 125 | barbed-end actin filament capping (GO:0051016) | 2.64524380 |
| 126 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.63546934 |
| 127 | vesicle coating (GO:0006901) | 2.63146991 |
| 128 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.63111432 |
| 129 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.63111432 |
| 130 | regulation of chromatin binding (GO:0035561) | 2.63103477 |
| 131 | anterior/posterior axis specification, embryo (GO:0008595) | 2.62889665 |
| 132 | regulation of sister chromatid segregation (GO:0033045) | 2.62804407 |
| 133 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.62804407 |
| 134 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.62804407 |
| 135 | regulation of translational termination (GO:0006449) | 2.62663157 |
| 136 | DNA strand elongation (GO:0022616) | 2.62409733 |
| 137 | regulation of sister chromatid cohesion (GO:0007063) | 2.61132075 |
| 138 | modulation by virus of host morphology or physiology (GO:0019048) | 2.58035974 |
| 139 | cellular hyperosmotic response (GO:0071474) | 2.57225985 |
| 140 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.56483984 |
| 141 | negative regulation of translational initiation (GO:0045947) | 2.56323914 |
| 142 | regulation of superoxide anion generation (GO:0032928) | 2.56004373 |
| 143 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.55932575 |
| 144 | cellular response to interleukin-4 (GO:0071353) | 2.55753758 |
| 145 | cell-substrate junction assembly (GO:0007044) | 2.55230226 |
| 146 | oxidative demethylation (GO:0070989) | 2.53462571 |
| 147 | negative regulation of mRNA processing (GO:0050686) | 2.52473018 |
| 148 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.51669831 |
| 149 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 2.51669831 |
| 150 | mRNA transport (GO:0051028) | 2.51297010 |
| 151 | negative regulation of gene silencing (GO:0060969) | 2.50731899 |
| 152 | protein localization to chromosome, centromeric region (GO:0071459) | 2.50284801 |
| 153 | oxaloacetate metabolic process (GO:0006107) | 2.50199136 |
| 154 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.50025232 |
| 155 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.50010720 |
| 156 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.49751842 |
| 157 | cellular response to topologically incorrect protein (GO:0035967) | 2.49046672 |
| 158 | snRNA processing (GO:0016180) | 2.48902076 |
| 159 | regulation of translational initiation (GO:0006446) | 2.48272751 |
| 160 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.46981578 |
| 161 | UMP metabolic process (GO:0046049) | 2.46981578 |
| 162 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.46981578 |
| 163 | UMP biosynthetic process (GO:0006222) | 2.46981578 |
| 164 | * spliceosomal snRNP assembly (GO:0000387) | 2.46217761 |
| 165 | metaphase plate congression (GO:0051310) | 2.45991498 |
| 166 | NIK/NF-kappaB signaling (GO:0038061) | 2.44715992 |
| 167 | proline biosynthetic process (GO:0006561) | 2.43649031 |
| 168 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.43212820 |
| 169 | pore complex assembly (GO:0046931) | 2.42961764 |
| 170 | monosaccharide biosynthetic process (GO:0046364) | 2.42874764 |
| 171 | DNA topological change (GO:0006265) | 2.42817053 |
| 172 | nuclear envelope reassembly (GO:0031468) | 2.42769421 |
| 173 | mitotic nuclear envelope reassembly (GO:0007084) | 2.42769421 |
| 174 | negative regulation of mRNA metabolic process (GO:1903312) | 2.42274387 |
| 175 | rRNA transcription (GO:0009303) | 2.41653988 |
| 176 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.41272396 |
| 177 | mannose metabolic process (GO:0006013) | 2.39978077 |
| 178 | protein insertion into membrane (GO:0051205) | 2.38523448 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.39869655 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.89348773 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.53879870 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.29417334 |
| 5 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.26152182 |
| 6 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.78546157 |
| 7 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.66794128 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.43543658 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.42922820 |
| 10 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.40816359 |
| 11 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.31399393 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.30737789 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.20784213 |
| 14 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.19812276 |
| 15 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.12953371 |
| 16 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.07888150 |
| 17 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.04915807 |
| 18 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.03508476 |
| 19 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.03084504 |
| 20 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.98947111 |
| 21 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.94748574 |
| 22 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.91396301 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.90054977 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.89632274 |
| 25 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.87377364 |
| 26 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.87039093 |
| 27 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.86371301 |
| 28 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.85183878 |
| 29 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.83750856 |
| 30 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.81722579 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.80092736 |
| 32 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.75748907 |
| 33 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.75482315 |
| 34 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.75306312 |
| 35 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.75235302 |
| 36 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.72368094 |
| 37 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.71966124 |
| 38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.71386592 |
| 39 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.68442256 |
| 40 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.67767804 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.67091159 |
| 42 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.64998699 |
| 43 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.64637768 |
| 44 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.64016032 |
| 45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.63493254 |
| 46 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.63041261 |
| 47 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.61085382 |
| 48 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.60816005 |
| 49 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.60745151 |
| 50 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60508678 |
| 51 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.56921284 |
| 52 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.56487659 |
| 53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.56339435 |
| 54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55893595 |
| 55 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.53586512 |
| 56 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.52810976 |
| 57 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.51518404 |
| 58 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.49292392 |
| 59 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.48219774 |
| 60 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.47622297 |
| 61 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.46088394 |
| 62 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.44760687 |
| 63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.44699085 |
| 64 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.43529923 |
| 65 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.42444810 |
| 66 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.42040872 |
| 67 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41922361 |
| 68 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.41043439 |
| 69 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.40721179 |
| 70 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.39846993 |
| 71 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.38273647 |
| 72 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.38273647 |
| 73 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.38273647 |
| 74 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35662288 |
| 75 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.35543747 |
| 76 | P68_20966046_ChIP-Seq_HELA_Human | 1.34888078 |
| 77 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.32337971 |
| 78 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.32112693 |
| 79 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.32061790 |
| 80 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.31423658 |
| 81 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.30688970 |
| 82 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.30646177 |
| 83 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.30565999 |
| 84 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.30413727 |
| 85 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.29297629 |
| 86 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27123689 |
| 87 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.26001016 |
| 88 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.24953220 |
| 89 | MAF_26560356_Chip-Seq_TH1_Human | 1.24850749 |
| 90 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.24678518 |
| 91 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.23806319 |
| 92 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.23269575 |
| 93 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.23015884 |
| 94 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.22080599 |
| 95 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.21978542 |
| 96 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.21823814 |
| 97 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.21775139 |
| 98 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.20380939 |
| 99 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.19870403 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.17549214 |
| 101 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.17242222 |
| 102 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.16998046 |
| 103 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.15826534 |
| 104 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.14625056 |
| 105 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.14504123 |
| 106 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13859713 |
| 107 | MAF_26560356_Chip-Seq_TH2_Human | 1.13835532 |
| 108 | UTX_26944678_Chip-Seq_JUKART_Human | 1.13507208 |
| 109 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13155374 |
| 110 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13100861 |
| 111 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.11416078 |
| 112 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.11318435 |
| 113 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.11271118 |
| 114 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.10769168 |
| 115 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.10139970 |
| 116 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08660199 |
| 117 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.08437132 |
| 118 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.08203409 |
| 119 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08165054 |
| 120 | KDM2B_26808549_Chip-Seq_K562_Human | 1.08116520 |
| 121 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07866042 |
| 122 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.07242381 |
| 123 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06612090 |
| 124 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06090026 |
| 125 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.04893681 |
| 126 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.04643344 |
| 127 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.04433066 |
| 128 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04012229 |
| 129 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.03290971 |
| 130 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02319730 |
| 131 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.02066056 |
| 132 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02017348 |
| 133 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01302791 |
| 134 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.01233334 |
| 135 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.00996337 |
| 136 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.00713100 |
| 137 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.00588227 |
| 138 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.00098374 |
| 139 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.99988454 |
| 140 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.99468103 |
| 141 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.99418985 |
| 142 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.98683290 |
| 143 | ATF3_27146783_Chip-Seq_COLON_Human | 0.98153422 |
| 144 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.97369582 |
| 145 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95864385 |
| 146 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.93875904 |
| 147 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.93816017 |
| 148 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.93341384 |
| 149 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.93231773 |
| 150 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.92412348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 4.27789690 |
| 2 | MP0008260_abnormal_autophagy | 3.60352786 |
| 3 | MP0003011_delayed_dark_adaptation | 3.45575661 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.21449532 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.07461283 |
| 6 | MP0010094_abnormal_chromosome_stability | 2.88943046 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 2.71318654 |
| 8 | MP0003111_abnormal_nucleus_morphology | 2.64563303 |
| 9 | MP0004957_abnormal_blastocyst_morpholog | 2.63386723 |
| 10 | MP0003077_abnormal_cell_cycle | 2.54058115 |
| 11 | MP0003123_paternal_imprinting | 2.48942042 |
| 12 | MP0010352_gastrointestinal_tract_polyps | 2.48456398 |
| 13 | MP0003693_abnormal_embryo_hatching | 2.47352637 |
| 14 | MP0002653_abnormal_ependyma_morphology | 2.33452189 |
| 15 | MP0002139_abnormal_hepatobiliary_system | 2.29273473 |
| 16 | MP0010307_abnormal_tumor_latency | 2.28037512 |
| 17 | MP0001730_embryonic_growth_arrest | 2.21811192 |
| 18 | MP0004233_abnormal_muscle_weight | 2.04202292 |
| 19 | MP0002877_abnormal_melanocyte_morpholog | 2.01520110 |
| 20 | MP0002796_impaired_skin_barrier | 1.99486387 |
| 21 | MP0005501_abnormal_skin_physiology | 1.92950155 |
| 22 | MP0001348_abnormal_lacrimal_gland | 1.87693011 |
| 23 | MP0003890_abnormal_embryonic-extraembry | 1.86287958 |
| 24 | MP0004185_abnormal_adipocyte_glucose | 1.83286616 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.75843345 |
| 26 | MP0002084_abnormal_developmental_patter | 1.72401042 |
| 27 | MP0008007_abnormal_cellular_replicative | 1.71040666 |
| 28 | MP0005380_embryogenesis_phenotype | 1.71008003 |
| 29 | MP0001672_abnormal_embryogenesis/_devel | 1.71008003 |
| 30 | MP0002089_abnormal_postnatal_growth/wei | 1.70730067 |
| 31 | MP0000350_abnormal_cell_proliferation | 1.69767071 |
| 32 | MP0005076_abnormal_cell_differentiation | 1.68135965 |
| 33 | MP0001697_abnormal_embryo_size | 1.67340447 |
| 34 | MP0003121_genomic_imprinting | 1.65901942 |
| 35 | MP0003453_abnormal_keratinocyte_physiol | 1.65039234 |
| 36 | MP0002086_abnormal_extraembryonic_tissu | 1.62154810 |
| 37 | MP0008058_abnormal_DNA_repair | 1.60307505 |
| 38 | MP0004858_abnormal_nervous_system | 1.59495444 |
| 39 | MP0002088_abnormal_embryonic_growth/wei | 1.58806472 |
| 40 | MP0003984_embryonic_growth_retardation | 1.58488472 |
| 41 | MP0010030_abnormal_orbit_morphology | 1.57186115 |
| 42 | MP0004197_abnormal_fetal_growth/weight/ | 1.53398328 |
| 43 | MP0000858_altered_metastatic_potential | 1.53031127 |
| 44 | MP0002080_prenatal_lethality | 1.51132528 |
| 45 | MP0002085_abnormal_embryonic_tissue | 1.50137217 |
| 46 | MP0003329_amyloid_beta_deposits | 1.49757869 |
| 47 | MP0009840_abnormal_foam_cell | 1.49011128 |
| 48 | MP0003252_abnormal_bile_duct | 1.46107654 |
| 49 | MP0001849_ear_inflammation | 1.43369474 |
| 50 | MP0003191_abnormal_cellular_cholesterol | 1.41503280 |
| 51 | MP0005085_abnormal_gallbladder_physiolo | 1.37560401 |
| 52 | MP0003786_premature_aging | 1.36655741 |
| 53 | MP0005257_abnormal_intraocular_pressure | 1.36306454 |
| 54 | MP0005365_abnormal_bile_salt | 1.35624585 |
| 55 | MP0000537_abnormal_urethra_morphology | 1.34117433 |
| 56 | MP0008438_abnormal_cutaneous_collagen | 1.33647787 |
| 57 | MP0003763_abnormal_thymus_physiology | 1.33199252 |
| 58 | MP0000747_muscle_weakness | 1.32396542 |
| 59 | MP0010329_abnormal_lipoprotein_level | 1.31519710 |
| 60 | MP0000751_myopathy | 1.31213350 |
| 61 | MP0005360_urolithiasis | 1.27654319 |
| 62 | MP0000678_abnormal_parathyroid_gland | 1.27585176 |
| 63 | MP0004133_heterotaxia | 1.26764944 |
| 64 | MP0005666_abnormal_adipose_tissue | 1.24659110 |
| 65 | MP0008932_abnormal_embryonic_tissue | 1.24503475 |
| 66 | MP0001915_intracranial_hemorrhage | 1.24384270 |
| 67 | MP0003186_abnormal_redox_activity | 1.22605487 |
| 68 | MP0003119_abnormal_digestive_system | 1.22342654 |
| 69 | MP0009333_abnormal_splenocyte_physiolog | 1.21517793 |
| 70 | MP0002060_abnormal_skin_morphology | 1.19083676 |
| 71 | MP0005023_abnormal_wound_healing | 1.16215142 |
| 72 | MP0009053_abnormal_anal_canal | 1.15263149 |
| 73 | MP0004019_abnormal_vitamin_homeostasis | 1.14541460 |
| 74 | MP0003718_maternal_effect | 1.12901711 |
| 75 | MP0004264_abnormal_extraembryonic_tissu | 1.12691574 |
| 76 | MP0008877_abnormal_DNA_methylation | 1.12497927 |
| 77 | MP0005409_darkened_coat_color | 1.11851099 |
| 78 | MP0009672_abnormal_birth_weight | 1.09974296 |
| 79 | MP0003300_gastrointestinal_ulcer | 1.08967435 |
| 80 | MP0003566_abnormal_cell_adhesion | 1.06487340 |
| 81 | MP0004381_abnormal_hair_follicle | 1.06230818 |
| 82 | MP0000358_abnormal_cell_content/ | 1.04189774 |
| 83 | MP0002166_altered_tumor_susceptibility | 1.04175281 |
| 84 | MP0004947_skin_inflammation | 1.03935706 |
| 85 | MP0000428_abnormal_craniofacial_morphol | 1.01994819 |
| 86 | MP0001873_stomach_inflammation | 0.99803995 |
| 87 | MP0005248_abnormal_Harderian_gland | 0.99562151 |
| 88 | MP0002098_abnormal_vibrissa_morphology | 0.98136205 |
| 89 | MP0001958_emphysema | 0.97450975 |
| 90 | MP0009278_abnormal_bone_marrow | 0.97212036 |
| 91 | MP0001346_abnormal_lacrimal_gland | 0.96517005 |
| 92 | MP0000733_abnormal_muscle_development | 0.95393619 |
| 93 | MP0000609_abnormal_liver_physiology | 0.94871775 |
| 94 | MP0000313_abnormal_cell_death | 0.94708191 |
| 95 | MP0002249_abnormal_larynx_morphology | 0.94602126 |
| 96 | MP0003115_abnormal_respiratory_system | 0.94506937 |
| 97 | MP0003283_abnormal_digestive_organ | 0.94344207 |
| 98 | MP0008961_abnormal_basal_metabolism | 0.93981652 |
| 99 | MP0003436_decreased_susceptibility_to | 0.93919603 |
| 100 | MP0000598_abnormal_liver_morphology | 0.93853672 |
| 101 | MP0001216_abnormal_epidermal_layer | 0.93493001 |
| 102 | MP0010234_abnormal_vibrissa_follicle | 0.93285757 |
| 103 | MP0000490_abnormal_crypts_of | 0.93104256 |
| 104 | MP0003122_maternal_imprinting | 0.92972980 |
| 105 | MP0000569_abnormal_digit_pigmentation | 0.92738062 |
| 106 | MP0001944_abnormal_pancreas_morphology | 0.91049598 |
| 107 | MP0001293_anophthalmia | 0.90562078 |
| 108 | MP0000759_abnormal_skeletal_muscle | 0.90403956 |
| 109 | MP0002970_abnormal_white_adipose | 0.90211611 |
| 110 | MP0002019_abnormal_tumor_incidence | 0.89588787 |
| 111 | MP0009931_abnormal_skin_appearance | 0.87833775 |
| 112 | MP0005395_other_phenotype | 0.87624394 |
| 113 | MP0000685_abnormal_immune_system | 0.87128867 |
| 114 | MP0008875_abnormal_xenobiotic_pharmacok | 0.86431312 |
| 115 | MP0005220_abnormal_exocrine_pancreas | 0.86284539 |
| 116 | MP0001727_abnormal_embryo_implantation | 0.85670722 |
| 117 | MP0004087_abnormal_muscle_fiber | 0.83441248 |
| 118 | MP0000003_abnormal_adipose_tissue | 0.82874690 |
| 119 | MP0000371_diluted_coat_color | 0.82443696 |
| 120 | MP0005375_adipose_tissue_phenotype | 0.81704834 |
| 121 | MP0003183_abnormal_peptide_metabolism | 0.80944540 |
| 122 | MP0003567_abnormal_fetal_cardiomyocyte | 0.77094735 |
| 123 | MP0006035_abnormal_mitochondrial_morpho | 0.76435184 |
| 124 | MP0002111_abnormal_tail_morphology | 0.76292483 |
| 125 | MP0002697_abnormal_eye_size | 0.75714492 |
| 126 | MP0003942_abnormal_urinary_system | 0.75396811 |
| 127 | MP0000377_abnormal_hair_follicle | 0.75340490 |
| 128 | MP0002269_muscular_atrophy | 0.74351796 |
| 129 | MP0002398_abnormal_bone_marrow | 0.74302770 |
| 130 | MP0003656_abnormal_erythrocyte_physiolo | 0.73936331 |
| 131 | MP0002254_reproductive_system_inflammat | 0.73934963 |
| 132 | MP0002396_abnormal_hematopoietic_system | 0.73886398 |
| 133 | MP0003221_abnormal_cardiomyocyte_apopto | 0.73828170 |
| 134 | MP0000467_abnormal_esophagus_morphology | 0.73727969 |
| 135 | MP0005621_abnormal_cell_physiology | 0.73305898 |
| 136 | MP0002925_abnormal_cardiovascular_devel | 0.72526410 |
| 137 | MP0000750_abnormal_muscle_regeneration | 0.71719100 |
| 138 | MP0000627_abnormal_mammary_gland | 0.71254887 |
| 139 | MP0001764_abnormal_homeostasis | 0.71050277 |
| 140 | MP0005384_cellular_phenotype | 0.69233355 |
| 141 | MP0000703_abnormal_thymus_morphology | 0.68479031 |
| 142 | MP0004808_abnormal_hematopoietic_stem | 0.67921139 |
| 143 | MP0001145_abnormal_male_reproductive | 0.67612225 |
| 144 | MP0002092_abnormal_eye_morphology | 0.67489834 |
| 145 | MP0005408_hypopigmentation | 0.66579614 |
| 146 | MP0000266_abnormal_heart_morphology | 0.66558370 |
| 147 | MP0010630_abnormal_cardiac_muscle | 0.66146540 |
| 148 | MP0002127_abnormal_cardiovascular_syste | 0.65598353 |
| 149 | MP0002168_other_aberrant_phenotype | 0.64749432 |
| 150 | MP0003091_abnormal_cell_migration | 0.64583834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperacusis (HP:0010780) | 4.41315867 |
| 2 | Ependymoma (HP:0002888) | 4.14558932 |
| 3 | Abnormal gallbladder physiology (HP:0012438) | 3.69261430 |
| 4 | Cholecystitis (HP:0001082) | 3.69261430 |
| 5 | Astrocytoma (HP:0009592) | 3.37670357 |
| 6 | Abnormality of the astrocytes (HP:0100707) | 3.37670357 |
| 7 | Increased connective tissue (HP:0009025) | 3.34058361 |
| 8 | Impulsivity (HP:0100710) | 3.30236788 |
| 9 | Insomnia (HP:0100785) | 3.22271692 |
| 10 | Distal lower limb amyotrophy (HP:0008944) | 3.07419285 |
| 11 | Hypoalphalipoproteinemia (HP:0003233) | 3.05743866 |
| 12 | Broad face (HP:0000283) | 2.98274317 |
| 13 | Selective tooth agenesis (HP:0001592) | 2.98076988 |
| 14 | Distal upper limb amyotrophy (HP:0007149) | 2.89147852 |
| 15 | Upper limb amyotrophy (HP:0009129) | 2.89147852 |
| 16 | Abnormality of the labia minora (HP:0012880) | 2.82192438 |
| 17 | Hypolipoproteinemia (HP:0010981) | 2.80599679 |
| 18 | Spastic diplegia (HP:0001264) | 2.80332324 |
| 19 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.74186916 |
| 20 | Cerebral aneurysm (HP:0004944) | 2.73235048 |
| 21 | Renovascular hypertension (HP:0100817) | 2.72315629 |
| 22 | Asymmetry of the thorax (HP:0001555) | 2.72313188 |
| 23 | Medulloblastoma (HP:0002885) | 2.69055798 |
| 24 | Achilles tendon contracture (HP:0001771) | 2.68012504 |
| 25 | Glioma (HP:0009733) | 2.66470661 |
| 26 | Ankle contracture (HP:0006466) | 2.66228814 |
| 27 | Vertebral compression fractures (HP:0002953) | 2.64994805 |
| 28 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.60719516 |
| 29 | Neoplasm of the oral cavity (HP:0100649) | 2.58406272 |
| 30 | Deviation of the thumb (HP:0009603) | 2.56332629 |
| 31 | Difficulty climbing stairs (HP:0003551) | 2.48785362 |
| 32 | Hypobetalipoproteinemia (HP:0003563) | 2.48741798 |
| 33 | Reticulocytosis (HP:0001923) | 2.48550647 |
| 34 | Deep venous thrombosis (HP:0002625) | 2.46794569 |
| 35 | Trismus (HP:0000211) | 2.45984971 |
| 36 | Hand muscle atrophy (HP:0009130) | 2.45228043 |
| 37 | Abnormality of the Achilles tendon (HP:0005109) | 2.45022475 |
| 38 | Proximal placement of thumb (HP:0009623) | 2.44776486 |
| 39 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.42499910 |
| 40 | Degeneration of anterior horn cells (HP:0002398) | 2.40848838 |
| 41 | Abnormality of the anterior horn cell (HP:0006802) | 2.40848838 |
| 42 | Flat acetabular roof (HP:0003180) | 2.40822154 |
| 43 | Micronodular cirrhosis (HP:0001413) | 2.39326918 |
| 44 | Adenoma sebaceum (HP:0009720) | 2.37051435 |
| 45 | Angiofibromas (HP:0010615) | 2.37051435 |
| 46 | Long palpebral fissure (HP:0000637) | 2.35956833 |
| 47 | Ragged-red muscle fibers (HP:0003200) | 2.35093264 |
| 48 | Distal lower limb muscle weakness (HP:0009053) | 2.33694682 |
| 49 | Colon cancer (HP:0003003) | 2.32709292 |
| 50 | Rhabdomyosarcoma (HP:0002859) | 2.28830133 |
| 51 | Intrahepatic cholestasis (HP:0001406) | 2.28039856 |
| 52 | Urethral obstruction (HP:0000796) | 2.25197912 |
| 53 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.24238341 |
| 54 | Protrusio acetabuli (HP:0003179) | 2.21465045 |
| 55 | Abnormality of the aortic arch (HP:0012303) | 2.18688195 |
| 56 | Broad distal phalanx of finger (HP:0009836) | 2.17586136 |
| 57 | Vascular calcification (HP:0004934) | 2.14401152 |
| 58 | Back pain (HP:0003418) | 2.12050623 |
| 59 | Progressive muscle weakness (HP:0003323) | 2.11425629 |
| 60 | Hemorrhage of the eye (HP:0011885) | 2.11192449 |
| 61 | Abnormal number of incisors (HP:0011064) | 2.11134693 |
| 62 | Neoplasm of striated muscle (HP:0009728) | 2.11020199 |
| 63 | Hepatocellular carcinoma (HP:0001402) | 2.10220317 |
| 64 | Cardiovascular calcification (HP:0011915) | 2.10059302 |
| 65 | Ulnar bowing (HP:0003031) | 2.08865417 |
| 66 | J-shaped sella turcica (HP:0002680) | 2.08854046 |
| 67 | Pointed chin (HP:0000307) | 2.08750086 |
| 68 | Progressive sensorineural hearing impairment (HP:0000408) | 2.08523533 |
| 69 | Volvulus (HP:0002580) | 2.07513675 |
| 70 | Subacute progressive viral hepatitis (HP:0006572) | 2.07065241 |
| 71 | Lower limb amyotrophy (HP:0007210) | 2.06781769 |
| 72 | Hyperglycinuria (HP:0003108) | 2.06562257 |
| 73 | Delayed puberty (HP:0000823) | 2.06031359 |
| 74 | Biliary tract neoplasm (HP:0100574) | 2.04326675 |
| 75 | Ketoacidosis (HP:0001993) | 2.03671175 |
| 76 | Cholelithiasis (HP:0001081) | 2.03063102 |
| 77 | Cellulitis (HP:0100658) | 2.02961398 |
| 78 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.01834439 |
| 79 | Orthostatic hypotension (HP:0001278) | 2.01829695 |
| 80 | Increased nuchal translucency (HP:0010880) | 2.00147742 |
| 81 | Birth length less than 3rd percentile (HP:0003561) | 1.99819530 |
| 82 | Overriding aorta (HP:0002623) | 1.99481515 |
| 83 | Microvesicular hepatic steatosis (HP:0001414) | 1.98321414 |
| 84 | Multiple enchondromatosis (HP:0005701) | 1.98191379 |
| 85 | Hypoglycemic coma (HP:0001325) | 1.98187506 |
| 86 | Truncal obesity (HP:0001956) | 1.97663981 |
| 87 | Elfin facies (HP:0004428) | 1.97121192 |
| 88 | Prominent nose (HP:0000448) | 1.96286360 |
| 89 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.94335551 |
| 90 | Chorioretinal atrophy (HP:0000533) | 1.94277539 |
| 91 | Advanced eruption of teeth (HP:0006288) | 1.94135687 |
| 92 | Biconcave vertebral bodies (HP:0004586) | 1.91201197 |
| 93 | Patellar dislocation (HP:0002999) | 1.91162132 |
| 94 | Bowel diverticulosis (HP:0005222) | 1.90943461 |
| 95 | Peripheral hypomyelination (HP:0007182) | 1.90357523 |
| 96 | Metaphyseal cupping (HP:0003021) | 1.90131036 |
| 97 | High pitched voice (HP:0001620) | 1.90090802 |
| 98 | Renal duplication (HP:0000075) | 1.90022133 |
| 99 | Progressive external ophthalmoplegia (HP:0000590) | 1.88124543 |
| 100 | Insulin resistance (HP:0000855) | 1.88094304 |
| 101 | Gastrointestinal carcinoma (HP:0002672) | 1.88063582 |
| 102 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.88063582 |
| 103 | Abnormality of the calcaneus (HP:0008364) | 1.87451594 |
| 104 | Hypercortisolism (HP:0001578) | 1.87308073 |
| 105 | Ketosis (HP:0001946) | 1.87250625 |
| 106 | Short nail (HP:0001799) | 1.86730363 |
| 107 | Stridor (HP:0010307) | 1.86208937 |
| 108 | Abnormality of the lower motor neuron (HP:0002366) | 1.85842398 |
| 109 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.85504292 |
| 110 | Premature rupture of membranes (HP:0001788) | 1.85108060 |
| 111 | Intestinal polyp (HP:0005266) | 1.84871336 |
| 112 | Aneurysm (HP:0002617) | 1.84285612 |
| 113 | Xanthomatosis (HP:0000991) | 1.84212741 |
| 114 | Ovarian neoplasm (HP:0100615) | 1.83796671 |
| 115 | Hyperglycinemia (HP:0002154) | 1.83598385 |
| 116 | Progressive hearing impairment (HP:0001730) | 1.82633596 |
| 117 | Entropion (HP:0000621) | 1.82474873 |
| 118 | Abnormal neuron morphology (HP:0012757) | 1.82310044 |
| 119 | Abnormality of the motor neurons (HP:0002450) | 1.82310044 |
| 120 | Intestinal polyposis (HP:0200008) | 1.81775381 |
| 121 | Agnosia (HP:0010524) | 1.81716351 |
| 122 | Myopathic facies (HP:0002058) | 1.81307303 |
| 123 | Abnormality of the thoracic spine (HP:0100711) | 1.81170239 |
| 124 | Cafe-au-lait spot (HP:0000957) | 1.80796177 |
| 125 | Dysmetric saccades (HP:0000641) | 1.80767691 |
| 126 | Abnormality of reticulocytes (HP:0004312) | 1.80145592 |
| 127 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.79310516 |
| 128 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.79310516 |
| 129 | Obsessive-compulsive behavior (HP:0000722) | 1.78566352 |
| 130 | Limb hypertonia (HP:0002509) | 1.78459113 |
| 131 | Thrombocytosis (HP:0001894) | 1.78138862 |
| 132 | Supranuclear gaze palsy (HP:0000605) | 1.78057883 |
| 133 | Hypertensive crisis (HP:0100735) | 1.77300673 |
| 134 | Insidious onset (HP:0003587) | 1.76924489 |
| 135 | Termporal pattern (HP:0011008) | 1.76924489 |
| 136 | Deep palmar crease (HP:0006191) | 1.76718892 |
| 137 | Secondary amenorrhea (HP:0000869) | 1.76425006 |
| 138 | Neoplasm of the liver (HP:0002896) | 1.75506013 |
| 139 | Growth hormone excess (HP:0000845) | 1.75306673 |
| 140 | Heterotopia (HP:0002282) | 1.73595733 |
| 141 | Neoplasm of the small intestine (HP:0100833) | 1.73575029 |
| 142 | Seborrheic dermatitis (HP:0001051) | 1.73498375 |
| 143 | Neuronal loss in central nervous system (HP:0002529) | 1.73496769 |
| 144 | Neoplasm of the pancreas (HP:0002894) | 1.73323432 |
| 145 | Fragile skin (HP:0001030) | 1.72649906 |
| 146 | Sparse lateral eyebrow (HP:0005338) | 1.72618032 |
| 147 | Flattened epiphyses (HP:0003071) | 1.72436921 |
| 148 | Epidermoid cyst (HP:0200040) | 1.71443818 |
| 149 | Hepatoblastoma (HP:0002884) | 1.71350630 |
| 150 | Abnormal pancreas size (HP:0012094) | 1.70611146 |
| 151 | Rough bone trabeculation (HP:0100670) | 1.69430051 |
| 152 | Shawl scrotum (HP:0000049) | 1.69171783 |
| 153 | Long eyelashes (HP:0000527) | 1.68185885 |
| 154 | Abnormality of glycolysis (HP:0004366) | 1.68153443 |
| 155 | Abnormality of nucleobase metabolism (HP:0010932) | 1.67995805 |
| 156 | Abnormal biliary tract morphology (HP:0012440) | 1.67877212 |
| 157 | Hammertoe (HP:0001765) | 1.67835191 |
| 158 | Asymmetric septal hypertrophy (HP:0001670) | 1.67790729 |
| 159 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.67493667 |
| 160 | Missing ribs (HP:0000921) | 1.67134724 |
| 161 | Hypoparathyroidism (HP:0000829) | 1.66513551 |
| 162 | Subcapsular cataract (HP:0000523) | 1.65797424 |
| 163 | Colitis (HP:0002583) | 1.65635560 |
| 164 | Foot dorsiflexor weakness (HP:0009027) | 1.65587319 |
| 165 | Apathy (HP:0000741) | 1.65139634 |
| 166 | Natal tooth (HP:0000695) | 1.64658755 |
| 167 | Distal sensory impairment (HP:0002936) | 1.64587799 |
| 168 | Absent thumb (HP:0009777) | 1.64417712 |
| 169 | Overlapping toe (HP:0001845) | 1.63893693 |
| 170 | Fibroma (HP:0010614) | 1.63815444 |
| 171 | Neoplasm of the rectum (HP:0100743) | 1.63432895 |
| 172 | Patellar aplasia (HP:0006443) | 1.63374594 |
| 173 | Hyperglycemia (HP:0003074) | 1.63139199 |
| 174 | Neoplasm of the colon (HP:0100273) | 1.62815985 |
| 175 | Cerebral inclusion bodies (HP:0100314) | 1.62780386 |
| 176 | Premature skin wrinkling (HP:0100678) | 1.60386711 |
| 177 | Abnormality of carpal bone ossification (HP:0006257) | 1.59636910 |
| 178 | Diminished motivation (HP:0000745) | 1.58979953 |
| 179 | Thoracic kyphosis (HP:0002942) | 1.58973725 |
| 180 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.57062535 |
| 181 | Abnormal gallbladder morphology (HP:0012437) | 1.56340891 |
| 182 | Abnormal ossification of hand bones (HP:0005921) | 1.52573107 |
| 183 | Hypokinesia (HP:0002375) | 1.51175521 |
| 184 | Hepatitis (HP:0012115) | 1.50386221 |
| 185 | Abnormality of the gallbladder (HP:0005264) | 1.50090224 |
| 186 | Disproportionate tall stature (HP:0001519) | 1.49587825 |
| 187 | Precocious puberty (HP:0000826) | 1.49569042 |
| 188 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.49021101 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SMG1 | 4.25179560 |
| 2 | CDK12 | 3.72358446 |
| 3 | PKN2 | 3.18043247 |
| 4 | BRD4 | 2.81697043 |
| 5 | EEF2K | 2.72291555 |
| 6 | CDC7 | 2.69189274 |
| 7 | PASK | 2.67777125 |
| 8 | NEK1 | 2.66884916 |
| 9 | NME2 | 2.63604375 |
| 10 | PTK6 | 2.62640700 |
| 11 | TSSK6 | 2.60997659 |
| 12 | MAP3K10 | 2.59462198 |
| 13 | TRIB3 | 2.34549707 |
| 14 | PRPF4B | 2.23723923 |
| 15 | BUB1 | 2.18784339 |
| 16 | TTK | 2.16833697 |
| 17 | STK10 | 2.07584877 |
| 18 | IRAK3 | 1.95786813 |
| 19 | SCYL2 | 1.94527829 |
| 20 | EPHA2 | 1.90796929 |
| 21 | NEK2 | 1.79713540 |
| 22 | MELK | 1.72857166 |
| 23 | RPS6KB2 | 1.72667845 |
| 24 | SIK1 | 1.68753939 |
| 25 | PLK1 | 1.64914710 |
| 26 | PAK4 | 1.60540870 |
| 27 | WEE1 | 1.58862911 |
| 28 | PDGFRA | 1.54706195 |
| 29 | FGFR1 | 1.42894112 |
| 30 | BCKDK | 1.41616439 |
| 31 | ATR | 1.40650855 |
| 32 | FLT3 | 1.40605368 |
| 33 | MAP3K13 | 1.38944065 |
| 34 | FGFR4 | 1.38146486 |
| 35 | MTOR | 1.35256299 |
| 36 | SIK2 | 1.29519809 |
| 37 | CDK7 | 1.23125283 |
| 38 | NEK9 | 1.22383526 |
| 39 | CCNB1 | 1.21791073 |
| 40 | TESK1 | 1.19973804 |
| 41 | TGFBR1 | 1.19589103 |
| 42 | ARAF | 1.19580310 |
| 43 | TTN | 1.17237828 |
| 44 | VRK2 | 1.15897629 |
| 45 | CDK4 | 1.14554406 |
| 46 | MAP3K8 | 1.14356952 |
| 47 | AURKB | 1.11805131 |
| 48 | EIF2AK1 | 1.11412420 |
| 49 | LRRK2 | 1.08907522 |
| 50 | PLK3 | 1.08003813 |
| 51 | MST1R | 1.07686820 |
| 52 | ERN1 | 1.07023311 |
| 53 | CHEK1 | 1.04533354 |
| 54 | SRPK1 | 1.04427849 |
| 55 | ALK | 1.01395835 |
| 56 | MAP2K2 | 1.00252622 |
| 57 | PTK2 | 0.98977401 |
| 58 | MAPKAPK3 | 0.96719625 |
| 59 | LATS1 | 0.93566699 |
| 60 | RET | 0.90685733 |
| 61 | CHEK2 | 0.90047208 |
| 62 | CDK6 | 0.88500743 |
| 63 | MAP3K11 | 0.86597189 |
| 64 | TBK1 | 0.84722984 |
| 65 | LMTK2 | 0.84064210 |
| 66 | TAOK2 | 0.82965601 |
| 67 | ERBB4 | 0.80995096 |
| 68 | CDK2 | 0.80633871 |
| 69 | MAP3K5 | 0.80600374 |
| 70 | STK3 | 0.76866909 |
| 71 | PLK4 | 0.75217241 |
| 72 | EPHB1 | 0.74906314 |
| 73 | ATM | 0.73146601 |
| 74 | PIM2 | 0.72541450 |
| 75 | GRK6 | 0.72304195 |
| 76 | MARK2 | 0.71924122 |
| 77 | AURKA | 0.71403905 |
| 78 | MAP3K14 | 0.69641663 |
| 79 | KSR2 | 0.68643996 |
| 80 | DAPK1 | 0.68262166 |
| 81 | RPS6KA4 | 0.67561707 |
| 82 | PRKD3 | 0.66415452 |
| 83 | CDK9 | 0.65914285 |
| 84 | PIM1 | 0.65333628 |
| 85 | CDK1 | 0.64390530 |
| 86 | CSNK1E | 0.63414352 |
| 87 | TLK1 | 0.62914302 |
| 88 | RIPK4 | 0.62606544 |
| 89 | RPS6KB1 | 0.61762433 |
| 90 | PRKD2 | 0.61586883 |
| 91 | NME1 | 0.61060260 |
| 92 | MAP2K3 | 0.60874144 |
| 93 | BMX | 0.60748944 |
| 94 | ICK | 0.60366915 |
| 95 | PDPK1 | 0.59861249 |
| 96 | MKNK1 | 0.56028406 |
| 97 | LATS2 | 0.55877148 |
| 98 | CHUK | 0.53641789 |
| 99 | PDK3 | 0.52847037 |
| 100 | PDK4 | 0.52847037 |
| 101 | DYRK1B | 0.52714770 |
| 102 | TYRO3 | 0.52622371 |
| 103 | MAP3K1 | 0.51569314 |
| 104 | DDR2 | 0.50819262 |
| 105 | RPS6KA2 | 0.50805074 |
| 106 | AKT2 | 0.50365410 |
| 107 | ITK | 0.50194010 |
| 108 | NTRK1 | 0.49692342 |
| 109 | TESK2 | 0.49368644 |
| 110 | CLK1 | 0.47341295 |
| 111 | BRAF | 0.46736834 |
| 112 | PAK2 | 0.43607679 |
| 113 | IRAK2 | 0.43504712 |
| 114 | KSR1 | 0.43384893 |
| 115 | CSF1R | 0.43193920 |
| 116 | CSNK2A2 | 0.42616187 |
| 117 | STK4 | 0.42433937 |
| 118 | CDK11A | 0.42261316 |
| 119 | HIPK2 | 0.41003912 |
| 120 | MAPK14 | 0.40900796 |
| 121 | MAP3K3 | 0.40222946 |
| 122 | CDC42BPA | 0.40152781 |
| 123 | FGFR2 | 0.40053615 |
| 124 | TAOK1 | 0.39634603 |
| 125 | ILK | 0.39514389 |
| 126 | PRKCI | 0.38699890 |
| 127 | CAMKK1 | 0.38152055 |
| 128 | MAPKAPK2 | 0.37683603 |
| 129 | RIPK1 | 0.36952318 |
| 130 | MAP3K9 | 0.36368094 |
| 131 | CDK15 | 0.36194724 |
| 132 | PRKDC | 0.35144291 |
| 133 | MAP3K7 | 0.34861485 |
| 134 | SIK3 | 0.33519947 |
| 135 | ACVR1B | 0.32214020 |
| 136 | MAP4K1 | 0.31781672 |
| 137 | MAPK1 | 0.31755932 |
| 138 | CAMK1D | 0.30751595 |
| 139 | FGFR3 | 0.30220861 |
| 140 | JAK2 | 0.30143023 |
| 141 | MOS | 0.29945923 |
| 142 | MAPK11 | 0.29070767 |
| 143 | CSNK1D | 0.28555056 |
| 144 | FER | 0.28513123 |
| 145 | AKT1 | 0.27290699 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | One carbon pool by folate_Homo sapiens_hsa00670 | 3.08638150 |
| 2 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 3.02866662 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.85858226 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.80318146 |
| 5 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.59098367 |
| 6 | RNA transport_Homo sapiens_hsa03013 | 2.53520500 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.51234392 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.38039700 |
| 9 | * Spliceosome_Homo sapiens_hsa03040 | 2.32409666 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.29735079 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.15207705 |
| 12 | Cell cycle_Homo sapiens_hsa04110 | 2.15157376 |
| 13 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.03385784 |
| 14 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.99290474 |
| 15 | Base excision repair_Homo sapiens_hsa03410 | 1.95525081 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.88482742 |
| 17 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.87077775 |
| 18 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.81271353 |
| 19 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.79145806 |
| 20 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.64772014 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.57795476 |
| 22 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.55173874 |
| 23 | Carbon metabolism_Homo sapiens_hsa01200 | 1.53954565 |
| 24 | Proteasome_Homo sapiens_hsa03050 | 1.51773677 |
| 25 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.49259057 |
| 26 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.46071619 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.44173783 |
| 28 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.43915443 |
| 29 | RNA polymerase_Homo sapiens_hsa03020 | 1.40850059 |
| 30 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.38616684 |
| 31 | Lysine degradation_Homo sapiens_hsa00310 | 1.38470522 |
| 32 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.37422153 |
| 33 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.37218938 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.36460671 |
| 35 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.34098665 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.30157405 |
| 37 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.25731213 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.24846840 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.24809004 |
| 40 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.23256259 |
| 41 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.21985223 |
| 42 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.18913761 |
| 43 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.17723042 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.13699318 |
| 45 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.12733746 |
| 46 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.12490394 |
| 47 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.10696359 |
| 48 | RNA degradation_Homo sapiens_hsa03018 | 1.10015116 |
| 49 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.09178973 |
| 50 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.09055754 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08874312 |
| 52 | Prion diseases_Homo sapiens_hsa05020 | 1.07284791 |
| 53 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.06843138 |
| 54 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.06696146 |
| 55 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.06560198 |
| 56 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.04364056 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.01570197 |
| 58 | Homologous recombination_Homo sapiens_hsa03440 | 1.01538320 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.00982161 |
| 60 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.00245900 |
| 61 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.00035884 |
| 62 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.97575549 |
| 63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.96365724 |
| 64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96208659 |
| 65 | Galactose metabolism_Homo sapiens_hsa00052 | 0.95207855 |
| 66 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.93973716 |
| 67 | Glioma_Homo sapiens_hsa05214 | 0.93362867 |
| 68 | Hepatitis B_Homo sapiens_hsa05161 | 0.92881385 |
| 69 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.92306474 |
| 70 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91581629 |
| 71 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.90612606 |
| 72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.90426034 |
| 73 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.90328254 |
| 74 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.89245234 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.89244810 |
| 76 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.88844432 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.87469219 |
| 78 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.86589565 |
| 79 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.86139342 |
| 80 | Hepatitis C_Homo sapiens_hsa05160 | 0.85714362 |
| 81 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.85163006 |
| 82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.85137885 |
| 83 | Endocytosis_Homo sapiens_hsa04144 | 0.83654719 |
| 84 | Colorectal cancer_Homo sapiens_hsa05210 | 0.78368034 |
| 85 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77243617 |
| 86 | HTLV-I infection_Homo sapiens_hsa05166 | 0.76827152 |
| 87 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76377305 |
| 88 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.76281826 |
| 89 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75994237 |
| 90 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.75371428 |
| 91 | Prostate cancer_Homo sapiens_hsa05215 | 0.74755913 |
| 92 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.73366830 |
| 93 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.73067164 |
| 94 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.72571279 |
| 95 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.71035184 |
| 96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69598371 |
| 97 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66856246 |
| 98 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.66727122 |
| 99 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.65644219 |
| 100 | Influenza A_Homo sapiens_hsa05164 | 0.64646444 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63627227 |
| 102 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63138382 |
| 103 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.62757448 |
| 104 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.62587732 |
| 105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62346074 |
| 106 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.62110958 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61895527 |
| 108 | Retinol metabolism_Homo sapiens_hsa00830 | 0.61771983 |
| 109 | Bladder cancer_Homo sapiens_hsa05219 | 0.61552144 |
| 110 | Viral myocarditis_Homo sapiens_hsa05416 | 0.61525034 |
| 111 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.61518316 |
| 112 | Adherens junction_Homo sapiens_hsa04520 | 0.60738314 |
| 113 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59397999 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.58547827 |
| 115 | Salmonella infection_Homo sapiens_hsa05132 | 0.58468119 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57325722 |
| 117 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.57263630 |
| 118 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57234924 |
| 119 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.56528122 |
| 120 | Peroxisome_Homo sapiens_hsa04146 | 0.56504420 |
| 121 | Lysosome_Homo sapiens_hsa04142 | 0.54838327 |
| 122 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54837338 |
| 123 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51053369 |
| 124 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.50880572 |
| 125 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49993026 |
| 126 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49738240 |
| 127 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.49360487 |
| 128 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47535675 |
| 129 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.47100688 |
| 130 | Focal adhesion_Homo sapiens_hsa04510 | 0.46842637 |
| 131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46611294 |
| 132 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.45499205 |
| 133 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45045023 |
| 134 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44727169 |
| 135 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43376371 |
| 136 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.43160259 |
| 137 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.42812097 |
| 138 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.42323234 |
| 139 | Ribosome_Homo sapiens_hsa03010 | 0.41997795 |
| 140 | Bile secretion_Homo sapiens_hsa04976 | 0.41895002 |
| 141 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.41494416 |
| 142 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.41491115 |
| 143 | Sulfur relay system_Homo sapiens_hsa04122 | 0.38940755 |
| 144 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37451587 |
| 145 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36251715 |
| 146 | Apoptosis_Homo sapiens_hsa04210 | 0.36073277 |
| 147 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.34551804 |
| 148 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.33675520 |

